↓ Skip to main content

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology

Overview of attention for article published in Lancet Oncology, June 2024
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
18 X users

Readers on

mendeley
86 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 86 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 13 15%
Student > Ph. D. Student 5 6%
Other 4 5%
Student > Bachelor 3 3%
Student > Doctoral Student 2 2%
Other 4 5%
Unknown 55 64%
Readers by discipline
Readers by discipline Count As %
Chemistry 9 10%
Medicine and Dentistry 8 9%
Physics and Astronomy 4 5%
Agricultural and Biological Sciences 2 2%
Chemical Engineering 1 1%
Other 6 7%
Unknown 56 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2024.
All research outputs
#4,911,540
of 34,518,599 outputs
Outputs from Lancet Oncology
#3,670
of 8,014 outputs
Outputs of similar age
#57,250
of 365,225 outputs
Outputs of similar age from Lancet Oncology
#53
of 103 outputs
Altmetric has tracked 34,518,599 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,014 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.4. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,225 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.